MedTrace Logo

Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application

NCT00995124 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2010-07-28

No results posted yet for this study

Summary

The purpose of this study is to compare the ovicidal activity of three head lice treatment products.

The study population will consist of Queensland primary school-aged children (Grades 1 - 7) who have at least 20 live eggs on the hair and who have not used any head lice product in the four weeks prior to the study.

Enrollment will continue to achieve 30 subjects in each treatment group (total of 90 subjects).

Conditions

  • Head Lice

Interventions

DRUG

NeutraLice Lotion

Head lice topical application to be applied once for 10 minutes.

DRUG

NeutraLice Advance Solution

head lice application to be applied once for 10 minutes

DRUG

Moov Head Lice Solution

Single application for head lice with 10 min application time.

Sponsors & Collaborators

  • Altman Biomedical Consulting Pty. Ltd.

    lead INDUSTRY

Principal Investigators

  • Stephen Barker, PhD · University of Queensland, Queensland, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Australia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00995124 on ClinicalTrials.gov